Testosterone for women, without the hype.

What testosterone can — and can't — do for women

The strongest evidence, summarized in the 2019 Global Consensus Position Statement endorsed by eleven international medical societies, supports one indication: hypoactive sexual desire disorder — distressing low sexual desire — in postmenopausal women. In trials, physiologic-dose testosterone improved desire, arousal, and sexual satisfaction in that group.

For the other claims you'll see advertised — energy, mood, "brain optimization," muscle, longevity — the honest answer is that current evidence is insufficient. We'll tell you that plainly, and we won't sell you testosterone on those promises.

How we prescribe it

• Physiologic dosing. The goal is to restore blood levels to the normal range for premenopausal women — not to push them above it. More is not better; it's just more side effects.
• Off-label, transparently. No testosterone product is currently FDA-approved for women in the U.S., so treatment uses careful low doses of approved products off-label — a lawful, guideline-acknowledged practice we'll explain before you start. Medication is prescribed only when clinically appropriate after evaluation by a licensed clinician.
• Levels monitored. Baseline testosterone before starting, then follow-up levels to keep dosing in the physiologic window and watch for side effects such as acne or unwanted hair growth.
• In context. Low desire has many drivers — relationship, mood, medications, sleep, genitourinary symptoms. Testosterone is one tool, considered after (often alongside) estrogen therapy and local vaginal estrogen where they fit.

We do not implant pellets. Here's why.